For example, patients with slower absorption patterns may benefit from abdominal injections consistently, while those with rapid absorption might alternate sites more frequently to maintain stable drug levels
Incretin based therapies such as GLP-1 receptor agonists have revolutionised management of type 2 diabetes by enhancing insulin secretion, slowing gastric emptying and reducing appetite (Dungan & DeSantis, 2025)
doi: 10.1007/S11154-014-9289-5 27 KalinderiKPapaliagkasVFidaniL
Trusting the Process GLP-1 medications such as Semaglutide and Liraglutide are used to support weight loss by helping regulate appetite, reduce cravings, and increase feelings of fullness
Factors such as adherence to the medication, individual metabolism, and lifestyle choices all influence the timeline for visible results
Access is gated mainly by cost, insurance coverage, and periodic supply constraints rather than by regulatory availability